China SXT Pharmaceuticals (SXTC) Other Working Capital Changes (2018 - 2025)

China SXT Pharmaceuticals' Other Working Capital Changes history runs 8 years deep, the most recent figure standing at $65057.0 for Q3 2025.

• In Q3 2025, Other Working Capital Changes fell 65.82% year-over-year to $65057.0; the TTM figure through Sep 2025 stood at $65057.0 (down 65.82% YoY), while the FY2025 annual figure was $58627.0, down 68.76% from the prior year.
• Other Working Capital Changes was $65057.0 for Q3 2025 at China SXT Pharmaceuticals, up from $58627.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $480227.0 in Q3 2021 to a low of $58627.0 in Q1 2025.
• Historically, Other Working Capital Changes has averaged $194438.2 across 5 years, with a median of $134411.0 in 2022.
• The sharpest annual moves came in 2021 and 2022: Other Working Capital Changes surged 358.17% in 2021, then plunged 77.22% in 2022.
• A 5-year view of Other Working Capital Changes shows it stood at $480227.0 in 2021, then slumped by 77.22% to $109411.0 in 2022, then surged by 33.49% to $146049.0 in 2023, then soared by 30.33% to $190340.0 in 2024, then slumped by 65.82% to $65057.0 in 2025.
• The last three Other Working Capital Changes figures came in at $65057.0 (Q3 2025), $58627.0 (Q1 2025), and $190340.0 (Q3 2024), per Business Quant data.